BELLICUM PHARMACEUTICALS

bellicum-pharmaceuticals-logo

Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.

#SimilarOrganizations #People #Financial #Website #More

BELLICUM PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Oncology Therapeutics

Founded:
2004-07-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.bellicum.com

Total Employee:
11+

Status:
Active

Contact:
(832) 384-1100

Email Addresses:
info@bellicum.com

Total Funding:
324.58 M USD

Technology used in webpage:
Domain Not Resolving IPv6 Pound Sterling Common Name Invalid Microsoft Japanese Yen COVID-19 Sectigo SSL Sectigo Domain SSL Unified Layer


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

aer-therapeutics-logo

Aer Therapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

cg-oncology-logo

CG Oncology

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

oric-pharmaceuticals-logo

ORIC Pharmaceuticals

ORIC Pharmaceuticals operates as a biopharmaceutical company.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells


Current Advisors List

not_available_image

Oliver Sartor Clinical Advisory Board @ Bellicum Pharmaceuticals
Advisor

philip-kantoff_image

Philip Kantoff Member of the Clinical Advisory Board @ Bellicum Pharmaceuticals
Advisor

not_available_image

Daniel P. Petrylak Clinical Advisory Board @ Bellicum Pharmaceuticals
Advisor

not_available_image

Frank B. McGuyer Board of Directors @ Bellicum Pharmaceuticals
Board_member

dennis-keith-stone_image

Dennis Keith Stone Board of Directors @ Bellicum Pharmaceuticals
Board_member

not_available_image

William K. Oh Clinical Advisory Board @ Bellicum Pharmaceuticals
Advisor

Current Employees Featured

kevin-slawin_image

Kevin Slawin
Kevin Slawin Founder @ Bellicum Pharmaceuticals
Founder
2004-01-01

aaron-foster_image

Aaron Foster
Aaron Foster Vice President of Product Discovery @ Bellicum Pharmaceuticals
Vice President of Product Discovery
2016-06-01

joseph-senesac_image

Joseph Senesac
Joseph Senesac Senior Vice President & Technical Operations @ Bellicum Pharmaceuticals
Senior Vice President & Technical Operations
2021-03-01

kevin-slawin_image

Kevin Slawin
Kevin Slawin Founder @ Bellicum Pharmaceuticals
Founder
2004-01-01

gregory-naeve_image

Gregory Naeve
Gregory Naeve Chief Business Officer @ Bellicum Pharmaceuticals
Chief Business Officer
2017-09-01

jaa-roberson_image

Jaa Roberson
Jaa Roberson Vice President, Human Resources @ Bellicum Pharmaceuticals
Vice President, Human Resources
2018-01-01

daniel-von-hoff_image

Daniel Von Hoff
Daniel Von Hoff Clinical Advisory Board @ Bellicum Pharmaceuticals
Clinical Advisory Board

william-grossman_image

William Grossman
William Grossman SVP, Chief Medical Officer @ Bellicum Pharmaceuticals
SVP, Chief Medical Officer
2018-01-01

rick-fair_image

Rick Fair
Rick Fair President & CEO @ Bellicum Pharmaceuticals
President & CEO
2017-01-01

annemarie-moseley_image

Annemarie Moseley
Annemarie Moseley Consultant @ Bellicum Pharmaceuticals
Consultant
2017-08-01

Founder


david-m-spencer_image

David M. Spencer

kevin-slawin_image

Kevin Slawin

Stock Details


Company's stock symbol is NASDAQ:BLCM

Investors List

cancer-prevention-and-research-institute-of-texas_image

Cancer Prevention and Research Institute of Texas

Cancer Prevention and Research Institute of Texas investment in Grant - Bellicum Pharmaceuticals

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Bellicum Pharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Bellicum Pharmaceuticals

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series C - Bellicum Pharmaceuticals

ridgeway-capital-partners_image

Ridgeway Capital Partners

Ridgeway Capital Partners investment in Series C - Bellicum Pharmaceuticals

sabby-capital_image

Sabby Capital

Sabby Capital investment in Series C - Bellicum Pharmaceuticals

aju-ib-investment_image

Aju IB Investment

Aju IB Investment investment in Series C - Bellicum Pharmaceuticals

jennison-associates_image

Jennison Associates

Jennison Associates investment in Series C - Bellicum Pharmaceuticals

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Bellicum Pharmaceuticals

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Bellicum Pharmaceuticals

Official Site Inspections

http://www.bellicum.com Semrush global rank: 3.9 M Semrush visits lastest month: 2.91 K

  • Host name: 192-185-225-144.unifiedlayer.com
  • IP address: 192.185.225.144
  • Location: Houston United States
  • Latitude: 29.8284
  • Longitude: -95.4696
  • Metro Code: 618
  • Timezone: America/Chicago
  • Postal: 77092

Loading ...

More informations about "Bellicum Pharmaceuticals"

Bellicum Pharmaceuticals

Feb 25, 2025 Bellicum was founded in 2004. The company has raised over $300 million in venture capital and public markets to date as it develops its pipeline of novel cellular …See details»

BeLocum | Pharmacy & Dental Staffing Solutions in Canada

Belocum provides top-tier pharmacy and dental staffing solutions across Canada. Discover the perfect match for your staffing needs with BelocumSee details»

Investor Center Home - Bellicum

Jan 31, 2023 Bellicum is a biopharmaceutical company that has engineered the newest wave of high-performance cellular technology, unleashing the power of potentially curative IO …See details»

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. (E xac t n ame of re gi s tr an t as s p e c i fi e d i n i ts c h ar te r ) D e l aw are. 20-1450200 (S tate or oth e r ju r i s d i c ti on of i n c or p or ati on or or gan i z …See details»

Bellicum Pharmaceuticals Company Profile & Introduction

Introduction of Bellicum Pharmaceuticals, including company profile, stock information, contact number, and company business introduction.See details»

bellicum.com - Whois.com

Whois Lookup for bellicum.com. Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Free services included with every domainSee details»

Search - Bellicum

The Investor Relations website contains information about Bellicum's business for stockholders, potential investors, and financial analysts.See details»

[2022] Bellicum Pharmaceuticals Inc Organizational Resilience …

Organization Resilience Introduction . The world is going through two major crises at the moment – Covid 19 health crisis and the on-going US China trade war that can determine the future of …See details»

Bellicum Pharmaceuticals Enters into Research Collaboration with …

Jun 2, 2016 New collaboration builds on current license and research agreement for TCR candidates, including BPX-701. HOUSTON--(BUSINESS WIRE)--Jun. 2, 2016-- Bellicum …See details»

Organization | Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Houston TX United States (2004 ... Organization Overview. First Clinical Trial. 2009 NCT00868595. …See details»

Bellicum Pharmaceuticals Company Profile -Sales, Contacts, …

Bellicum Pharmaceuticals, Inc. (trade name BELLICUM) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number. Enter company …See details»

Bellicum - 2025 Company Profile, Funding & Competitors - Tracxn

Apr 11, 2025 Bellicum has raised a total funding of $138M over 11 rounds. Its first funding round was on Oct 09, 2007. Its latest funding round was a Series C round on Sep 02, 2014 for …See details»

Bellicum Pharmaceuticals, Inc. (Bellicum Pharmaceuticals, Inc.) - 药 …

May 7, 2025 了解Bellicum Pharmaceuticals, Inc. (Bellicum Pharmaceuticals, Inc.)公司的药物管线,治疗领域,技术平台,以及它的28项临床试验, 70篇新闻和88篇文献,疾病领域:肿瘤,免 …See details»

Bellicum Reports First Quarter 2021 Financial Results and Provides ...

May 17, 2021 Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update 05/17/21 at 7:30 AM EDT HOUSTON, May 17, 2021 (GLOBE NEWSWIRE) -- …See details»

Bellicum Pharmaceuticals Inc | AP News - Associated Press News

Mideast Wars Israel-Hamas War Russia-Ukraine War Global elections ESPAÑOL China Asia PacificSee details»

Bellicum - Overview, News & Similar companies | ZoomInfo.com

Mar 14, 2023 Who is Bellicum. Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular …See details»

Bellicum’s Competitors, Revenue, Number of Employees, Funding …

Bellicum’s Profile, Revenue and Employees. Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders. Bellicum’s primary …See details»

Bellicum Pharmaceuticals Company Profile & Introduction

May 21, 2025 Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological …See details»

About BELLICUM PHARMACEUTICALS, INC | DxMultiomics

Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company’s next-generation product candidates are …See details»

Bellicum Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

May 7, 2025 Explore Bellicum Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 28 clinical trials, 63 news, and 88 literature, Disease Domain:Neoplasms, …See details»

linkstock.net © 2022. All rights reserved